Workflow
奥赛康深度汇报
002755ASK PHARM(002755) -·2024-07-20 04:41

Summary of Conference Call Company/Industry Involved - The conference call pertains to Changjiang Securities Research Institute, specifically for whitelist clients only [1] Core Points and Arguments - The content of the conference call is confidential and cannot be disclosed or reproduced without prior written permission from Changjiang Securities [1] - Any unauthorized dissemination of the conference call content will result in legal consequences for the individual or institution involved [1] Other Important but Possibly Overlooked Content - Changjiang Securities reserves the right to pursue legal action against any unauthorized use of the conference call information [1]